Arecor to present on Investor Meet Company
No summary for this filing – the full text is below.
Select text to share a quote on X · sign in to keep highlights & notes in your AREC notes
Cambridge, UK, 27 September 2024: Arecor Therapeutics plc (AIM: AREC), the biopharmaceutical group advancing today's therapies to enable healthier lives, today announces that Sarah Howell, Chief Executive Officer, will be providing a live presentation of the Group's recently announced interim results for the six months ended 30 June 2024 via the Investor Meet Company platform, on Thursday 3 October at 3pm BST.
The presentation is open to all existing and potential shareholders and will be followed by a Q&A session. Questions can be submitted ahead of the event through the Investor Meet Company dashboard up until 9am BST on Wednesday 2 October 2024, or at any time during the live presentation.
To sign up to Investor Meet Company for free and to register for Arecor's presentation, please visit:
Investors who already follow Arecor on the Investor Meet Company platform will automatically be invited to the event.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.